Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small M...
Lonza seeks SGX trading halt lift for shares listed on SGX-ST
Lonza shares halt on SGX pending news release
Lonza shares on SGX halt pending news release
13:11 ETLonza Issues Exclusive, Target-Specific License to Antharis Therapeutics to Advance Next-Generation Dual Payload ADCs for Gastrointestinal Cancers
Lonza: Q1 Performance In Line With Expectations; Confirms 2026 Outlook
Lonza says big pharma might delay outsourcing decisions amid US investments